Microvast (MVST) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Aug, 2026Executive summary
Q2 2026 revenue was $87.3 million, down 4.5% year-over-year, mainly due to a $2.7 million tariff refund to a U.S. customer and lower demand in key markets.
Gross margin declined to 29.5% from 34.7% in Q2 2025, impacted by higher raw material costs and lower production utilization.
Net loss for Q2 2026 was $12.0 million, a significant improvement from $106.1 million in Q2 2025, primarily due to reduced negative impacts from warrant liability and convertible loan revaluations.
Adjusted EBITDA for Q2 2026 was $3.6 million, down from $25.9 million in Q2 2025.
Ended the period with $143.1 million in cash, a decrease of $26.2 million from the prior period.
Financial highlights
Q2 2026 gross profit was $25.8 million, with gross margin at 29.5%.
Operating expenses rose 16.1% year-over-year to $27.5 million in Q2, driven by higher legal, professional, and R&D costs.
Net cash used in operating activities was $33.3 million for the first half, a significant swing from $44.3 million generated in the prior year.
Capital expenditures totaled $15.5 million year-to-date, mainly for U.S. office purchase and Huzhou expansion.
Cash and equivalents at quarter-end: $143.1 million.
Outlook and guidance
Strategic priorities for H2 2026 include accelerating profitability, scaling with margin discipline, and expanding in heavy industry and transit markets.
Huzhou Phase 3.2 expansion is expected to add up to 2 GWh of annual production capacity, with SOP in 2026.
Clarksville, TN pack line assembly is on track for initial output by year-end; full-scale plant construction depends on additional financing or partnerships.
Management expects continued operating losses and negative cash flows, with ongoing reliance on external capital.
Plans to commercialize next-generation products and expand into new high-margin market segments.
Latest events from Microvast
- Revenue dropped 48% year-over-year, but margin resilience and fair value gains supported results.MVST
Q1 2026 - Record revenue and positive adjusted EBITDA, despite margin hit from inventory impairment.MVST
Q4 2025 - Offering up to $250M in securities to support growth in U.S. battery technology and production.MVST
Registration Filing - Up to $250M in securities offered; major stockholder may sell 5.5M shares; broad risk factors disclosed.MVST
Registration Filing - Annual meeting to elect directors, ratify auditor, and address governance and compliance.MVST
Proxy Filing - Virtual meeting to elect director, ratify auditor, and address governance and compensation.MVST
Proxy Filing - Q3 profit and 27% revenue growth driven by EMEA, but liquidity and expansion risks persist.MVST
Q3 2024 - Q2 revenue up 12% to $83.7M, EMEA surged, but net loss widened on impairment and liquidity risks.MVST
Q2 2024 - Record revenue, margin gains, and $401M backlog support strong 2025 growth outlook.MVST
Q4 2024